Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine plus Cisplatin in metastatic breast cancer
NCT00191815Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gemcitabine in breast cancer, sponsored by Eli Lilly and Company. Started Oct 2002; status: completed.
02
Drugs
gemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00191815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191815.